Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography–mass spectrometry profiling: Relevance to doping control analysis
2017 ◽
Vol 145
◽
pp. 555-568
◽
2008 ◽
Vol 876
(1)
◽
pp. 47-53
◽
2008 ◽
Vol 33
(1)
◽
pp. 91-99
◽
2019 ◽
Vol 38
(2)
◽
pp. 500-510
◽
2020 ◽
Vol 136
◽
pp. 105423
◽
2015 ◽
Vol 997
◽
pp. 236-243
◽
2015 ◽
Vol 383-384
◽
pp. 23-30
◽
2003 ◽
Vol 31
(2)
◽
pp. 233-241
◽
1995 ◽
Vol 669
(2)
◽
pp. 247-263
◽